Article
JNJ's Bladder Cancer Therapy Meets Key Goal in Early-Stage Study
Strong Bullish
100.0
−100 Bearish
0
+100 Bullish
J&J reports phase I study win for Erda-iDRS in NMIBC, showing strong response rates, durable control and manageable safety as mid-to-late-stage studies advance.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Source
finance.yahoo.com
Published
Mar 16, 2026 · 4:59 pm
Article ID
KL99IJZ
Original URL
Open source
Sentiment Signal
Strong Bullish
100.0
−100Neutral+100
More Like This